Figure 2
- ID
- ZDB-FIG-210716-88
- Publication
- Lima Cunha et al., 2021 - REP1-deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia
- Other Figures
- All Figure Page
- Back to All Figure Page
CHM patients exhibit evidence of increased oxidative stress. (A) Schematic of the glutathione metabolism pathway, where several compounds were found to be increased (red) or decreased (green) in CHM patients compared with controls. Metabolites trending to significance (0.05 < P ≤ 0.1) are represented in a lighter shade to distinguish from those significantly altered (P ≤ 0.05). (B–I) Scatter dot plots of specific metabolites indicating the mean ± SD levels in CHM patient samples (red) and control samples (blue) (n = 25). P value was determined using matched pair t tests. #0.05 < P ≤ 0.1, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. |